Quantcast
Channel: MassDevice
Browsing all 11157 articles
Browse latest View live

Image may be NSFW.
Clik here to view.

Resonetics plans Minnesota laser micro-manufacturing plant

Resonetics said today it is opening a laser micro-manufacturing facility in Plymouth, Minn. Get the full story at our sister site, Medical Design & Outsourcing.   The post Resonetics plans...

View Article


Image may be NSFW.
Clik here to view.

Appeals court overturns triple damages in Zimmer Biomet’s $280m patent loss...

A federal appeals court today overturned the enhanced damages and attorney fees awarded in Stryker‘s (NYSE:SYK) $70 million patent infringement win over Zimmer Biomet (NYSE:ZBH), but upheld its prior...

View Article


Image may be NSFW.
Clik here to view.

Terumo, CytoSorbents ink cardiac surgery deal

Terumo Corp. (TYO:4543) said today it inked a strategic partnership deal with CytoSorbents to commercialize its CytoSorb blood purification adsorber for cardiac surgery applications. New Jersey-based...

View Article

Image may be NSFW.
Clik here to view.

Private equity player Vance Street Capital acquires Motion Dynamics

Private equity player Vance Street Capital said it invested an unspecified amount in Motion Dynamics Corp. and its wire-based components business. Los Angeles-based Vance Street said Motion Dynamics is...

View Article

Image may be NSFW.
Clik here to view.

Biotronik touts dual drug-coated balloon-stent therapy for lower-limb disease

Biotronik today released data from studies of its Pulsar-18 bare metal self-expanding stent and Passeo-18 Lux drug-coated ballon, touting high rates or primary patency and freedom from target lesion...

View Article


Image may be NSFW.
Clik here to view.

AstraZeneca, Bespak ink deal for metered-dose inhaler

AstraZeneca (NYSE:AZN) said last week that it inked a multi-year commercial supply deal with Consort Medical (LON:CSRT) subsidiary Bespak for its pressurized metered-dose inhaler technology. Bespak...

View Article

Image may be NSFW.
Clik here to view.

Novocure touts long-term analysis of Optune drug-device combo

Novocure (NSDQ: NVCR) touted a long-term analysis of data from a Phase III pivotal trial of its Optune device in combination with temozolomide for the treatment of newly-formed glioblastomas. Survival...

View Article

Image may be NSFW.
Clik here to view.

Chemists develop 3D bone-scanning technique

Chemists at Trinity College Dublin created a 3D bone-scanning technique that does not expose patients to radiation. The team attached a luminescent tag to tiny, gold structures called nanoagents. The...

View Article


Image may be NSFW.
Clik here to view.

Nordisk issues voluntary recall of GlucaGen HypoKits

Novo Nordisk (NYSE:NVO) issued a voluntary recall of 6 batches of its GlucaGen HypoKits in the U.S., after reports of detached needles in the syringes. The company initiated the recall following 2...

View Article


Image may be NSFW.
Clik here to view.

Coapt looks to bring prosthetic electrodes into the 21st century

When Jodie O’Connell was 16, she lost her right arm in a meat-grinding accident. She was given a prosthetic, but quickly came to hate it. It was a standard myoelectric system: Two electrodes, 1...

View Article

Image may be NSFW.
Clik here to view.

MassDevice.com +5 | The top 5 medtech stories for September 12, 2016

Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...

View Article

Image may be NSFW.
Clik here to view.

FDA OKs expanded trial for Precision Biopsy’s ClariCore prostate biopsy device

Precision Biopsy said today it won an investigational device exemption from the FDA to expand the trial of its ClariCore biopsy system, now looking to enroll prostate cancer patients in the newly...

View Article

Image may be NSFW.
Clik here to view.

Survey: The Fractured State of Enterprise Sales Enablement and Training

According to a recent Allego survey, 73% of salespeople in the medical/pharmaceutical industry believe insights from reps in the field would improve the sales enablement process at their company....

View Article


Image may be NSFW.
Clik here to view.

Orthofix launches study of pulsed electromagnetic fields in treating...

Orthofix (NSDQ:OFIX) said today it enrolled the 1st patient in a study exploring the use of its Physio-Stim pulsed electromagnetic field system for treating osteoarthritis of the knee. The Lewisville,...

View Article

Image may be NSFW.
Clik here to view.

Ethicon wins FDA nod for Enseal X1 tissue sealer

Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon  said today it won FDA 510(k) clearance for its Enseal X1 large jaw tissue sealer designed for vessel sealing and precise heat management. The...

View Article


Image may be NSFW.
Clik here to view.

Abbott touts 38% hypoglycemia reduction in FreeStyle Libre study

Abbott (NYSE:ABT) today released data from the Impact study of its FreeStyle Libre glucose monitor, touting significantly reduced hypoglycemia in type 1 diabetes patients. Data from the 328-patient...

View Article

Image may be NSFW.
Clik here to view.

ReWalk Robotics founder’s Upnride wheelchair lets you cruise through town...

(Reuters) — Israeli technology start-up Upnride Robotics is launching an innovative upright, self-stabilizing wheelchair at a medical conference in Germany next month and hopes to hit the market next...

View Article


Image may be NSFW.
Clik here to view.

Insulet launches artificial pancreas feasibility trial for Omnipod Horizon...

Insulet (NSDQ:PODD) said today that it’s launching a clinical trial of an artificial pancreas system based on its flagship Omnipod insulin management device for treating Type I diabetes. The Omnipod...

View Article

Image may be NSFW.
Clik here to view.

MDSAP authorities push for medical device industry participation

By Stewart Eisenhart, Emergo Group Officials overseeing the Medical Device Single Audit Program (MDSAP) developed to allow single quality system audits across multiple regulatory jurisdictions have...

View Article

Image may be NSFW.
Clik here to view.

FDA approves Medtronic’s In.Pact Admiral DCB for in-stent restenosis

Medtronic (NYSE:MDT) said today it won FDA premarket approval for its In.Pact Admiral drug-coated balloon with indications for treating in-stent restenosis in peripheral artery disease patients. The...

View Article
Browsing all 11157 articles
Browse latest View live


Latest Images